This proposal was generated in response to RFA DA-93-01 and is designed to establish in vivo neurochemical and electrophysiological correlates of cocaine-seeking behaviors that can then be used to design potential novel treatment drugs for cocaine dependence. These animal models are designed to permit assessment of the neurochemical and physiological basis of cocaine reward magnitude, strength of cocaine-seeking behaviors (""""""""craving""""""""), and the """"""""propensity to relapse"""""""" in limited access and the dependent state. Behavioral parameters of various cocaine-seeking behaviors will be established in rats with different histories of cocaine preexposure. Specifically, cocaine-seeking behaviors of rats with a history of daily limited-access cocaine self-administration will be compared to those exhibited by rats given extended access to cocaine. The proposed studies will examine whether the behavioral manifestations of cocaine """"""""craving"""""""" are subserved by the same or different, neuropharmacological substrates as the acute reinforcing effects of cocaine. To accomplish these goals, behavioral parameters of responding for cocaine under different reinforcement contingencies will be established in rats after episodes of extended-access cocaine self- administration using progressive ratio, and multiple schedules. Repeated extinction and spontaneous recovery tests in the presence and absence of environmental cues associated with cocaine availability will provide information about the persistence of cocaine-seeking behaviors. Neurochemical correlates of these behavioral measures will be established using intracranial microdialysis for dopamine and serotonin in various forebrain sites. Neurophysiological correlates of these behavioral methods will be measured using extracellular recording techniques in freely-moving rats at various forebrain sites. Novel pharmacological therapies will be developed by determining effective pharmacological means of reversing the neurochemical (in vivo microdialysis) and electrophysiological (extracellular recording) changes associated with these various components of cocaine-seeking behavior in both limited-access and dependent animals. Treatments effective in modifying these neuropharmacological events will then be tested in the behavioral paradigms for potential pharmacotherapeutic action. These studies will provide important, presently unavailable insights into the neuropharmacological substrate(s) mediating specific cocaine-seeking behaviors as well as information about the relationship between self-administration history and cocaine-seeking behaviors. Finally, the work in this proposal will provide a novel means for the development of specific and novel drugs with therapeutic potential for treating or preventing cocaine abuse and dependence.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA008467-03
Application #
2120961
Study Section
Special Emphasis Panel (SRCD (11))
Project Start
1993-09-01
Project End
1998-08-31
Budget Start
1995-09-01
Budget End
1996-08-31
Support Year
3
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Martin-Fardon, Rémi; Cauvi, Gabrielle; Kerr, Tony M et al. (2018) Differential role of hypothalamic orexin/hypocretin neurons in reward seeking motivated by cocaine versus palatable food. Addict Biol 23:6-15
Martin-Fardon, Rémi; Weiss, Friedbert (2017) Perseveration of craving: effects of stimuli conditioned to drugs of abuse versus conventional reinforcers differing in demand. Addict Biol 22:923-932
Matzeu, Alessandra; Cauvi, Gabrielle; Kerr, Tony M et al. (2017) The paraventricular nucleus of the thalamus is differentially recruited by stimuli conditioned to the availability of cocaine versus palatable food. Addict Biol 22:70-77
Matzeu, Alessandra; Kerr, Tony M; Weiss, Friedbert et al. (2016) Orexin-A/Hypocretin-1 Mediates Cocaine-Seeking Behavior in the Posterior Paraventricular Nucleus of the Thalamus via Orexin/Hypocretin Receptor-2. J Pharmacol Exp Ther 359:273-279
Matzeu, A; Weiss, F; Martin-Fardon, R (2015) Transient inactivation of the posterior paraventricular nucleus of the thalamus blocks cocaine-seeking behavior. Neurosci Lett 608:34-9
Martin-Fardon, Rémi; Weiss, Friedbert (2014) Blockade of hypocretin receptor-1 preferentially prevents cocaine seeking: comparison with natural reward seeking. Neuroreport 25:485-8
Zorrilla, Eric P; Wee, Sunmee; Zhao, Yu et al. (2012) Extended access cocaine self-administration differentially activates dorsal raphe and amygdala corticotropin-releasing factor systems in rats. Addict Biol 17:300-8
Martin-Fardon, Rémi; Zorrilla, Eric P; Ciccocioppo, Roberto et al. (2010) Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin. Brain Res 1314:145-61
Martin-Fardon, R; Baptista, M A S; Dayas, C V et al. (2009) Dissociation of the effects of MTEP [3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]piperidine] on conditioned reinstatement and reinforcement: comparison between cocaine and a conventional reinforcer. J Pharmacol Exp Ther 329:1084-90
Aujla, Harinder; Martin-Fardon, Remi; Weiss, Friedbert (2008) Rats with extended access to cocaine exhibit increased stress reactivity and sensitivity to the anxiolytic-like effects of the mGluR 2/3 agonist LY379268 during abstinence. Neuropsychopharmacology 33:1818-26

Showing the most recent 10 out of 41 publications